The Food and Drug Administration (“FDA”) has warned hundreds of medical practices in this country that they could have received medications not approved for use in the US, including Botox, that may be dangerous to patients. With the upswing of Botox use during the holiday season, the warning is timely.
The FDA statement notes that healthcare providers in this country purchased medications from foreign suppliers that may be contaminated, ineffective and perhaps unsafe. The suppliers are reportedly owned by Canada Drugs and distributed under the names Quality Specialty Products, A+ Health Supplies, QP Medical, Bridgewater Medical and Clinical Care, per the agency statement.
These drugs are not approved and should not be administered to patients, the agency cautioned.
Virginia Buchanan is a shareholder at Levin, Papantonio. She has served on the Board of Directions of the Florida Bar Foundation and has been Treasurer of ABOTA, Chairperson of the Civil Process Server Grievance Committee and has been a member of the Chief Judge’s Council on Children. She currently is a member of the Women’s Caucus of the Florida Justice Association.